<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03695601</url>
  </required_header>
  <id_info>
    <org_study_id>SN-C-00011</org_study_id>
    <nct_id>NCT03695601</nct_id>
  </id_info>
  <brief_title>Surveillance HeartCare® Outcomes Registry</brief_title>
  <acronym>SHORE</acronym>
  <official_title>Surveillance HeartCare® Outcomes Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CareDx</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CareDx</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an observational registry to assess the clinical utility of surveillance using
      HeartCare testing services, in association with clinical care of heart transplant recipients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      HeartCare is a service which includes AlloMap® and AlloSure-Heart® to provide information to
      help clinicians to more comprehensively monitor heart transplant recipients for allograft
      rejection. An approach to surveillance using HeartCare provides information from two
      complementary measures; AlloMap is a gene-expression profile based measure of host immune
      activity and risk of acute rejection. AlloSure-Heart monitors graft injury. AlloMap is the
      first FDA cleared test and is the only non-invasive, blood test method recommended in the
      International Society for Heart and Lung Transplantation (ISHLT) guidelines for surveillance
      of heart transplant recipients for rejection. AlloSure-Heart measures donor-derived cell-free
      DNA (dd-cfDNA) to help discriminate acute cellular rejection and antibody-mediated rejection
      from no rejection. Patients who receive HeartCare, as part of their post-transplant
      management, will give informed consent for information on their outcomes and other relevant
      clinical information, found in their medical records, to be entered into a SHORE database for
      purposes of the study.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 28, 2018</start_date>
  <completion_date type="Anticipated">June 2027</completion_date>
  <primary_completion_date type="Anticipated">December 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of patients alive at one, two and three years post-transplantation.</measure>
    <time_frame>Dec-2024</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">1600</enrollment>
  <condition>Heart Transplant Rejection</condition>
  <arm_group>
    <arm_group_label>HeartCare</arm_group_label>
    <description>Diagnostic Test: Heart Care 1600 patients managed with HeartCare (AlloMap® and AlloSure-Heart® )</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>A historical control group will be matched to the estimated 800 HeartCare group patients who complete at least two years of HeartCare surveillance use and inclusive of year 3 post-transplant clinical follow-up for outcome. The criteria for the matched controls will be based on allograft donor type, age, gender, ethnicity/race, and other clinical factors. Propensity scores will be used to perform the matching.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard of Care</intervention_name>
    <description>Other Standard measures for monitoring rejection: Endomyocardial Biopsy, Echocardiogram, Angiography, Intravascular Ultrasound, Donor-specific HLA Antibody</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>HeartCare</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      For AlloMap, RNA isolated from peripheral blood mononuclear cells (PBMC) For AlloSure-Heart,
      plasma from venous blood will be collected and cell-free DNA will be extracted from the
      plasma for analysis of donor-derived cell-free DNA
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All eligible heart transplant recipients who meet the inclusion/exclusion criteria will be
        a part of this observational study.

        The control cohort will include the historical patients cared for without the use of
        HeartCare at the participating centers.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients who are 15 years of age or older at the time of blood draw.

          2. Heart transplant recipients who are selected by their health care provider to be
             managed with HeartCare.

          3. Patients who are selected by their health care provider to be managed following the
             Heart Routine Testing Schedule (HARTS) or a derivative of the schedule that has been
             defined by the provider.

          4. Patients who provide written informed consent.

          5. Patients who have HeartCare initiated within 30 days of signing the informed consent
             form.

        Exclusion Criteria:

          1. Patients who are less than 15 years of age at the time of blood draw.

          2. Heart transplant recipients who are not managed with HeartCare.

          3. Patients who are not managed following the Heart Routine Testing Schedule (HARTS) or a
             derivative of the schedule that has been defined by the provider.

          4. Patients who are pregnant at the time of blood draw.

          5. Patients who do not provide written informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James P Yee, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>CareDx</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sham Dholakia</last_name>
    <phone>415-287-2374</phone>
    <email>sdholakia@caredx.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>UC San Diego</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carol Battikha</last_name>
      <phone>858-246-2407</phone>
      <email>celiasbattikha@ucsd.edu</email>
    </contact>
    <investigator>
      <last_name>Paul Kim, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cedars-Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Irina Cozianu</last_name>
      <phone>310-248-7134</phone>
      <email>irina.cozianu@cshs.org</email>
    </contact>
    <investigator>
      <last_name>Jon Kobashigawa, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Gordon</last_name>
      <email>jgordon9@stanford.edu</email>
    </contact>
    <contact_backup>
      <last_name>Helen Luikart</last_name>
      <email>luikart@stanford.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Kiran Khush, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jeffrey Teuteberg, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Yale New Haven</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06519</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lynn Wilson</last_name>
      <email>lynn.m.wilson@yale.edu</email>
    </contact>
    <investigator>
      <last_name>Lavanya Bellumkonda, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lissett Moni</last_name>
      <email>Ltueros@med.miami.edu</email>
    </contact>
    <investigator>
      <last_name>Sandra Chaparro, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AdventHealth</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32804</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gladys Mendez</last_name>
      <email>Gladys.mendezcordero@Adventhealth.com</email>
    </contact>
    <contact_backup>
      <last_name>Anne Epley</last_name>
      <email>anne.epley@AdventHealth.com</email>
    </contact_backup>
    <investigator>
      <last_name>Nirav Raval, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Piedmont Heart Institute</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30309</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrew Bailey, RN</last_name>
      <phone>404-605-4098</phone>
      <email>Andrew.bailey@piedmont.org</email>
    </contact>
    <investigator>
      <last_name>Arun Krishnamoorthy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Huskin</last_name>
      <email>Anna.Huskin@nm.org</email>
    </contact>
    <investigator>
      <last_name>Kambiz Ghafourian, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Loyola University Medical Center</name>
      <address>
        <city>Maywood</city>
        <state>Illinois</state>
        <zip>60153</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carol Kartje</last_name>
      <email>ckartje@luc.edu</email>
    </contact>
    <investigator>
      <last_name>Max Liebo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Vincent Hospital</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46290</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melanie Glover</last_name>
      <email>Melanie.Glover@ascension.org</email>
    </contact>
    <investigator>
      <last_name>Ashwin Ravichandran, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tufts Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Telfer</last_name>
      <email>ltelfer@tuftsmedicalcenter.org</email>
    </contact>
    <investigator>
      <last_name>Amanda Vest, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diane Cocca-Spofford</last_name>
      <email>Cocca-Spofford.Diane@mgh.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Gregory Lewis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Henry Ford Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shereen Mukhashen</last_name>
      <email>smukhas2@hfhs.org</email>
    </contact>
    <investigator>
      <last_name>Cristina Tita, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Luke's Hospital of Kansas City</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karen Haffey</last_name>
      <email>khaffey@saint-lukes.org</email>
    </contact>
    <contact_backup>
      <last_name>Luciana Santaularia</last_name>
      <email>lsantaularia@saint-lukes.org</email>
    </contact_backup>
    <investigator>
      <last_name>Andrew Kao, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Barnes Jewish Hospital, Washington University</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Annie Dirks</last_name>
      <email>aplatts@wustl.edu</email>
    </contact>
    <investigator>
      <last_name>Gregory Ewald, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwell Health/ North Shore University Hospital</name>
      <address>
        <city>Manhasset</city>
        <state>New York</state>
        <zip>11030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Keriann Leppla</last_name>
      <email>KLeppla@northwell.edu</email>
    </contact>
    <investigator>
      <last_name>Gerin Stevens, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Albatou Bensitel</last_name>
      <email>bensita@ccf.org</email>
    </contact>
    <investigator>
      <last_name>Eileen Hsich, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shawna Oxier</last_name>
      <email>Shawna.oxier@osumc.edu</email>
    </contact>
    <investigator>
      <last_name>Brent Lampert, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Penn State Health Milton S. Hershey Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kevin Gardner</last_name>
      <email>kgardner@pennstatehealth.psu.edu</email>
    </contact>
    <investigator>
      <last_name>Howard Eisen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katie Strachan</last_name>
      <email>caitlin.strachan@pennmedicine.upenn.edu</email>
    </contact>
    <investigator>
      <last_name>Rhondalyn C Forde-Mclean, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Allegheny-Singer Research Institute</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Meghana Bohra</last_name>
      <email>Meghana.Bohra@ahn.org</email>
    </contact>
    <investigator>
      <last_name>Manreet Kanwar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Kunkel, RN</last_name>
      <phone>412-647-4463</phone>
      <email>kunkelme@upmc.edu</email>
    </contact>
    <investigator>
      <last_name>Mary Keeble, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Seton Heart Institute</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Virginia Remeny, RN, CNS</last_name>
      <phone>512-324-9999</phone>
      <phone_ext>18125</phone_ext>
      <email>VdRemeny@ascension.org</email>
    </contact>
    <investigator>
      <last_name>Mary Beth Cishek, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baylor Research Institute</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75246</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shane Blankenship</last_name>
      <phone>214-818-7639</phone>
      <email>shane.blankenship@bswhealth.org</email>
    </contact>
    <investigator>
      <last_name>Shelley Hall, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UT Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carolyn Kelly</last_name>
      <phone>214-645-8040</phone>
      <email>Carolyn.Kelley@utsouthwestern.edu</email>
    </contact>
    <investigator>
      <last_name>Pradeep Mammen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baylor St. Luke's Medical Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melyssa Fink</last_name>
      <email>Melyssa.Fink@bcm.edu</email>
    </contact>
    <investigator>
      <last_name>Ajith Nair, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Houston Methodist Research Institute</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marcos DeOlivera</last_name>
      <phone>346-238-0218</phone>
      <email>mdeoliveira@houstonmethodist.org</email>
    </contact>
    <investigator>
      <last_name>Ashrith Guha, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Intermountain Heart Institute</name>
      <address>
        <city>Murray</city>
        <state>Utah</state>
        <zip>84107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heather Maestas</last_name>
      <phone>801-507-4951</phone>
      <email>Heather.Maestas@imail.org</email>
    </contact>
    <investigator>
      <last_name>Rami Alharethi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Inova Fairfax Medical Campus</name>
      <address>
        <city>Falls Church</city>
        <state>Virginia</state>
        <zip>22042</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie Garfalo</last_name>
      <email>stephanie.garfalo@inova.org</email>
    </contact>
    <investigator>
      <last_name>Palak Shah, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Wisconsin School of Medicine and Public Health</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53726</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karen Olson, RN</last_name>
      <phone>608-263-1544</phone>
      <email>kjolson@medicine.wisc.edu</email>
    </contact>
    <investigator>
      <last_name>RAvi Dhingra, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Aurora Health Care</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Reva Matz, RN</last_name>
      <email>reva.matz@aurora.org</email>
    </contact>
    <investigator>
      <last_name>Nasir Sulemanjee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Agbor-Enoh S, Tunc I, De Vlaminck I, Fideli U, Davis A, Cuttin K, Bhatti K, Marishta A, Solomon MA, Jackson A, Graninger G, Harper B, Luikart H, Wylie J, Wang X, Berry G, Marboe C, Khush K, Zhu J, Valantine H. Applying rigor and reproducibility standards to assay donor-derived cell-free DNA as a non-invasive method for detection of acute rejection and graft injury after heart transplantation. J Heart Lung Transplant. 2017 Sep;36(9):1004-1012. doi: 10.1016/j.healun.2017.05.026. Epub 2017 May 20.</citation>
    <PMID>28624139</PMID>
  </reference>
  <reference>
    <citation>Crespo-Leiro MG, Stypmann J, Schulz U, Zuckermann A, Mohacsi P, Bara C, Ross H, Parameshwar J, Zakliczyński M, Fiocchi R, Hoefer D, Colvin M, Deng MC, Leprince P, Elashoff B, Yee JP, Vanhaecke J. Clinical usefulness of gene-expression profile to rule out acute rejection after heart transplantation: CARGO II. Eur Heart J. 2016 Sep 1;37(33):2591-601. doi: 10.1093/eurheartj/ehv682. Epub 2016 Jan 7.</citation>
    <PMID>26746629</PMID>
  </reference>
  <reference>
    <citation>De Vlaminck I, Valantine HA, Snyder TM, Strehl C, Cohen G, Luikart H, Neff NF, Okamoto J, Bernstein D, Weisshaar D, Quake SR, Khush KK. Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection. Sci Transl Med. 2014 Jun 18;6(241):241ra77. doi: 10.1126/scitranslmed.3007803.</citation>
    <PMID>24944192</PMID>
  </reference>
  <reference>
    <citation>Deng MC, Eisen HJ, Mehra MR, Billingham M, Marboe CC, Berry G, Kobashigawa J, Johnson FL, Starling RC, Murali S, Pauly DF, Baron H, Wohlgemuth JG, Woodward RN, Klingler TM, Walther D, Lal PG, Rosenberg S, Hunt S; CARGO Investigators. Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant. 2006 Jan;6(1):150-60.</citation>
    <PMID>16433769</PMID>
  </reference>
  <reference>
    <citation>Grskovic M, Hiller DJ, Eubank LA, Sninsky JJ, Christopherson C, Collins JP, Thompson K, Song M, Wang YS, Ross D, Nelles MJ, Yee JP, Wilber JC, Crespo-Leiro MG, Scott SL, Woodward RN. Validation of a Clinical-Grade Assay to Measure Donor-Derived Cell-Free DNA in Solid Organ Transplant Recipients. J Mol Diagn. 2016 Nov;18(6):890-902. doi: 10.1016/j.jmoldx.2016.07.003. Epub 2016 Oct 7.</citation>
    <PMID>27727019</PMID>
  </reference>
  <reference>
    <citation>Kobashigawa J, Patel J, Azarbal B, Kittleson M, Chang D, Czer L, Daun T, Luu M, Trento A, Cheng R, Esmailian F. Randomized pilot trial of gene expression profiling versus heart biopsy in the first year after heart transplant: early invasive monitoring attenuation through gene expression trial. Circ Heart Fail. 2015 May;8(3):557-64. doi: 10.1161/CIRCHEARTFAILURE.114.001658. Epub 2015 Feb 19.</citation>
    <PMID>25697852</PMID>
  </reference>
  <reference>
    <citation>Pham MX, Teuteberg JJ, Kfoury AG, Starling RC, Deng MC, Cappola TP, Kao A, Anderson AS, Cotts WG, Ewald GA, Baran DA, Bogaev RC, Elashoff B, Baron H, Yee J, Valantine HA; IMAGE Study Group. Gene-expression profiling for rejection surveillance after cardiac transplantation. N Engl J Med. 2010 May 20;362(20):1890-900. doi: 10.1056/NEJMoa0912965. Epub 2010 Apr 22.</citation>
    <PMID>20413602</PMID>
  </reference>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>September 28, 2018</study_first_submitted>
  <study_first_submitted_qc>October 2, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 4, 2018</study_first_posted>
  <last_update_submitted>June 19, 2020</last_update_submitted>
  <last_update_submitted_qc>June 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

